Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Hylomorph logo — pioneering innovation in preventive medicine

Hylomorph

pioneering innovation in preventive medicine

Founded 2015 Switzerland Zurich, Switzerland 12 employees Series B Total: $16.33M Health Care, Medical Devices

General Information

Company Name Hylomorph
Founded Year 2015
Location Switzerland Zurich, Switzerland
Employees 12
Industries Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Hylomorph. To contact Hylomorph, visit hylomorph-medical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hylomorph compare?

A PDF of Hylomorph and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hylomorph soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hylomorph

Hylomorph is an innovative Medtech company based in Switzerland, founded in 2014. The company aims to prevent post-operative complications in implantable medical devices by engineering biomaterials to optimize the interface between implants and surrounding biological tissues. With the mission to improve the quality of life for patients and the care provided by health professionals, Hylomorph has developed proprietary CellSense technology in collaboration with the cutting-edge laboratories of the Swiss Federal Institute of Technology (ETH Zurich).

The company's first product, Hylomate, has shown remarkable performance in limiting foreign body reaction and fibrotic buildup in pre-clinical settings. Currently, it is undergoing first-in-man clinical trials in Germany. Hylomorph has recently secured a significant Fr.4.50M Series B investment led by a consortium of investors including Verve Ventures, EFI Lake Geneva Ventures, Excellis, The Investors Club, Interconsult, StartAngels Network, and Zürcher Kantonal Bank on 05 September 2023.

Business keywords: Medtech, Biomaterials, Implantable Medical Devices, CellSense Technology, Medical Technology, Surgical Complications, Quality of Life, Healthcare Innovation, Clinical Trials, Biological Tissues Interface, Fibrotic Buildup, Neurostimulation, Electrophysiology, Swiss Federal Institute of Technology, Innovative Healthcare Solutions

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Fr.4.50M 7
Verve Ventures EFI Lake Geneva Ventures Excellis
Verve Ventures, EFI Lake Geneva Ventures +5
05 Sep 2023
Grant Fr.2.40M 1
Innosuisse
Innosuisse
28 Apr 2023
Non Equity Assistance Fr.900.00K -
03 Dec 2021
Series B Fr.5.20M 5
Verve Ventures Efficient Frontier Investing
Verve Ventures, Efficient Frontier Investing +3
03 Dec 2021
Grant Undisclosed 1
Eurostars
19 Mar 2019
Series A Fr.3.20M 4
Verve Ventures Fongit Seed Invest
Verve Ventures, Fongit Seed Invest +2
14 Sep 2018
Pre Seed Round Fr.100.00K 1
Venture Kick
Venture Kick
20 Jan 2016
Grant Fr.20.00K 1
Venture Kick
Venture Kick
04 Apr 2015
Grant Fr.10.00K 1
Venture Kick
Venture Kick
13 Jan 2015

Hylomorph Alternatives & Competitors

View All Alternatives
Hylomorph vs
Canary Medical Inc.
Canary Medical Inc. Canada

Giving medical devices a voice and letting medical data be heard

Series C
78 employees
Health Care, Medical Devices
Hylomorph vs
VISION CARE CENTER LIMITED
VISION CARE CENTER LIMITED

Enhancing Quality of Life Through Advanced Vision Solutions

Venture round
2 employees
Health Care, Medical Devices
Hylomorph vs
Inspire Medical Systems
Inspire Medical Systems United States

We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea.

Post-IPO Equity
1195 employees
Biotechnology, Health Care
View all alternatives

FAQ About Hylomorph

pioneering innovation in preventive medicine
Hylomorph was founded in 2015.
Hylomorph is headquartered in Zurich, Switzerland.
Hylomorph operates in Health Care and Medical Devices. Its work centres on Medtech, Biomaterials, Implantable Medical Devices and CellSense Technology.
Hylomorph has approximately 12 employees.
Hylomorph has completed 9 funding rounds, raising a total of $16.33M. The latest funding stage is Series B.
Top alternatives and competitors to Hylomorph include Canary Medical Inc., VISION CARE CENTER LIMITED, Inspire Medical Systems, ZOLL Respicardia, IPaDiC BV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hylomorph and Canary Medical Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hylomorph, https://bouncewatch.com/company/hylomorph, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout